{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:24:34Z","timestamp":1769729074917,"version":"3.49.0"},"reference-count":104,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2375,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1111\/j.1529-8019.2009.01224.x","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T15:19:55Z","timestamp":1237994395000},"page":"110-128","source":"Crossref","is-referenced-by-count":18,"title":["Existing antiviral vaccines"],"prefix":"10.1155","volume":"22","author":[{"given":"Parisa","family":"Ravanfar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Satyaprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosella","family":"Creed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB1","first-page":"129","author":"Centers for Disease Control and Prevention","year":"2008"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB2","volume-title":"Measles vaccine","author":"Strebel","year":"2004"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB3","first-page":"147","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2008"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB4","first-page":"159","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2008"},{"issue":"RR-8","key":"10.1111\/j.1529-8019.2009.01224.x-BIB5","first-page":"1","article-title":"Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"47","author":"Watson","year":"1998","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01224.x-BIB6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1542\/peds.97.5.613","article-title":"An evaluation of measles revaccination among school-entry-aged children","volume":"97","author":"Watson","year":"1996","journal-title":"Pediatrics"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01224.x-BIB7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00006454-199002000-00008","article-title":"Duration of live measles vaccine-induced immunity","volume":"9","author":"Markowitz","year":"1990","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archpedi.1980.04490010008003","article-title":"RA27\/3 rubella vaccine. A four-year follow-up","volume":"134","author":"Balfour","year":"1980","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/inf.1973.5.issue-4.01","article-title":"Vaccination against rubella of newly delivered women","volume":"5","author":"Grillner","year":"1973","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01224.x-BIB10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3181\/00379727-165-40979","article-title":"Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27\/3 rubella virus","volume":"165","author":"Weibel","year":"1980","journal-title":"Proc Soc Exp Biol Med"},{"issue":"8229","key":"10.1111\/j.1529-8019.2009.01224.x-BIB11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(81)92243-1","article-title":"Rubella viraemia and antibody responses after rubella vaccination and reimmunization","volume":"1","author":"Balfour","year":"1981","journal-title":"Lancet"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/infdis\/148.4.639","article-title":"Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus","volume":"148","author":"O'Shea","year":"1983","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00006454-198307000-00005","article-title":"Clinical efficacy of rubella vaccine","volume":"2","author":"Greaves","year":"1983","journal-title":"Pediatr Infect Dis"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB14","first-page":"25","article-title":"Rubella epidemic in an institution: protective value of live rubella vaccine and serological behavior of vaccinated, revaccinated and naturally immune groups","volume":"21","author":"Baba","year":"1978","journal-title":"Biken J"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01224.x-BIB15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/oxfordjournals.aje.a114387","article-title":"Prevalence of rubella antibodies in Massachusetts schoolchildren","volume":"124","author":"Orenstein","year":"1986","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB16","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/clinids\/7.Supplement_1.S80","article-title":"Persistence of vaccine-induced immune responses to rubella: comparison with natural infection","volume":"7","author":"Horstmann","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01224.x-BIB17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.1973.03220330013003","article-title":"Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States","volume":"225","author":"Plotkin","year":"1973","journal-title":"JAMA"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01224.x-BIB18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM196702022760501","article-title":"Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation","volume":"276","author":"Weibel","year":"1967","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1111\/j.1529-8019.2009.01224.x-BIB19","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1001\/jama.1987.03390180073026","article-title":"The effect of a school entry law on mumps activity in a school district","volume":"257","author":"Chaiken","year":"1987","journal-title":"JAMA"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.aje.a114037","article-title":"Clinical mumps vaccine efficacy","volume":"121","author":"Kim-Farley","year":"1985","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01224.x-BIB21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3476(05)80726-7","article-title":"Mumps outbreak in a highly vaccinated population","volume":"119","author":"Hersh","year":"1991","journal-title":"J Pediatr"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/infdis\/169.1.77","article-title":"Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity","volume":"169","author":"Briss","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB23","unstructured":"23.\u2002MMR vaccine. Available at: http:\/\/www.cdc.gov\/vaccines\/pubs\/vis\/downloads\/vis-mmr.pdf. Accessed October 30, 2008."},{"issue":"RR-1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB24","first-page":"1","article-title":"General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"43","year":"1994","unstructured":"24.\u2002General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1994: 43 (RR-1): 1-38.","journal-title":"MMWR Recomm Rep"},{"issue":"8487","key":"10.1111\/j.1529-8019.2009.01224.x-BIB25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(86)91044-5","article-title":"Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins","volume":"1","author":"Peltola","year":"1986","journal-title":"Lancet"},{"issue":"RR-5","key":"10.1111\/j.1529-8019.2009.01224.x-BIB26","first-page":"1","article-title":"Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Prevots","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01224.x-BIB27","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/aje\/136.7.769","article-title":"Epidemiology of the post-polio syndrome","volume":"136","author":"Ramlow","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01224.x-BIB28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","article-title":"Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease","volume":"14","author":"Strebel","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01224.x-BIB29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archpedi.1994.02170050037007","article-title":"Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease","volume":"148","author":"Prevots","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB30","first-page":"79","article-title":"Paralytic poliomyelitis - United States, 1980-1994","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB31","first-page":"151","article-title":"The production of inactivated polio vaccine on serially cultivated kidney cells from captive-bred monkeys","volume":"46","author":"van Wezel","year":"1980","journal-title":"Dev Biol Stand"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB32","first-page":"1","article-title":"International Symposium on Reassessment of Inactivated Poliomyelitis Vaccine. Bilthoven, the Netherlands, June 24-17, 1980","volume":"47","year":"1981","unstructured":"32.\u2002International Symposium on Reassessment of Inactivated Poliomyelitis Vaccine. Bilthoven, the Netherlands, June 24-17, 1980. Dev Biol Stand 1981: 47: 1-361.","journal-title":"Dev Biol Stand"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01224.x-BIB33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/oxfordjournals.aje.a115009","article-title":"Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines","volume":"128","author":"McBean","year":"1988","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01224.x-BIB34","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/162.6.1291","article-title":"Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses","volume":"162","author":"Faden","year":"1990","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB35","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/infdis\/175.Supplement_1.S228","article-title":"Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group","volume":"175","author":"Modlin","year":"1997","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1111\/j.1529-8019.2009.01224.x-BIB36","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.4049\/jimmunol.162.8.5011","article-title":"Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus","volume":"162","author":"Herremans","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0022172400040389","article-title":"A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living polio vaccine","volume":"64","author":"Henry","year":"1966","journal-title":"J Hyg (London)"},{"issue":"27","key":"10.1111\/j.1529-8019.2009.01224.x-BIB39","first-page":"590","article-title":"Recommendations of the Advisory Committee on Immunization Practices: revised recommendations for routine poliomyelitis vaccination","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01224.x-BIB40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1086\/516312","article-title":"Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination","volume":"26","author":"Prevots","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB41","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/infdis\/175.Supplement_1.S165","article-title":"Outbreaks of paralytic poliomyelitis, 1976-1995","volume":"175","author":"Patriarca","year":"1997","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01224.x-BIB42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJM197708042970505","article-title":"Recommendations for a national policy on poliomyelitis vaccination","volume":"297","author":"Nightingale","year":"1977","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01224.x-BIB43","first-page":"22","article-title":"Poliomyelitis prevention","volume":"31","author":"Centers for Disease Control and Prevention","year":"1982","journal-title":"MMWR"},{"issue":"48","key":"10.1111\/j.1529-8019.2009.01224.x-BIB44","first-page":"795","article-title":"Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine - supplementary statement","volume":"36","author":"Centers for Disease Control and Prevention","year":"1987","journal-title":"MMWR"},{"issue":"8888","key":"10.1111\/j.1529-8019.2009.01224.x-BIB45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(94)90903-2","article-title":"Vaccine-associated paralytic poliomyelitis and HIV infection","volume":"343","author":"Ion-Nedelcu","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01224.x-BIB46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3476(94)70307-8","article-title":"Epidemiology of Guillain-Barre syndrome in children: relationship of oral polio vaccine administration to occurrence","volume":"124","author":"Rantala","year":"1994","journal-title":"J Pediatr"},{"issue":"10","key":"10.1111\/j.1529-8019.2009.01224.x-BIB47","first-page":"789","article-title":"Unsafe injections in the developing world and transmission of bloodborne pathogens: a review","volume":"77","author":"Simonsen","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB48","first-page":"299","volume-title":"Hepatitis B vaccine","author":"Mast","year":"2004"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB49","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"McMahon","year":"1985","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF01951493","article-title":"Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection","volume":"3","author":"Dienstag","year":"1981","journal-title":"Springer Semin Immunopathol"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB51","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/20.4.992","article-title":"Risks of chronicity following acute hepatitis B virus infection: a review","volume":"20","author":"Hyams","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"RR-16","key":"10.1111\/j.1529-8019.2009.01224.x-BIB52","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0163-4453(86)92563-6","article-title":"Production and immunological analysis of recombinant hepatitis B vaccine","volume":"13","author":"Emini","year":"1986","journal-title":"J Infect"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB54","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/0264-410X(90)90221-7","article-title":"Development and production aspects of a recombinant yeast-derived hepatitis B vaccine","volume":"8","author":"Stephenne","year":"1990","journal-title":"Vaccine"},{"issue":"19","key":"10.1111\/j.1529-8019.2009.01224.x-BIB55","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.291.19.2351","article-title":"Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage","volume":"291","author":"Luman","year":"2004","journal-title":"JAMA"},{"issue":"8","key":"10.1111\/j.1529-8019.2009.01224.x-BIB56","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jama.284.8.978","article-title":"Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series","volume":"284","author":"Yusuf","year":"2000","journal-title":"JAMA"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01224.x-BIB57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0264-410X(97)00233-8","article-title":"A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults","volume":"16","author":"Marsano","year":"1998","journal-title":"Vaccine"},{"issue":"16","key":"10.1111\/j.1529-8019.2009.01224.x-BIB58","first-page":"2097","article-title":"Alternate two-dose hepatitis B vaccination schedule for adolescents aged 11-15 years","volume":"283","author":"From the Centers for Disease Control and Prevention","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB59","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatr"},{"issue":"20","key":"10.1111\/j.1529-8019.2009.01224.x-BIB60","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.1994.03510440062034","article-title":"Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine","volume":"271","author":"Stratton","year":"1994","journal-title":"JAMA"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01224.x-BIB61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1542\/peds.109.5.839","article-title":"Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization","volume":"109","author":"Armstrong","year":"2002","journal-title":"Pediatr"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB62","volume-title":"Health information for international travel","author":"Centers for Disease Control and Prevention","year":"2007"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01224.x-BIB63","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.1970.03170190035005","article-title":"Viral hepatitis. New light on an old disease","volume":"212","author":"Krugman","year":"1970","journal-title":"JAMA"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005792-199201000-00002","article-title":"Relapsing hepatitis A. Review of 14 cases and literature survey","volume":"71","author":"Glikson","year":"1992","journal-title":"Medicine"},{"issue":"RR-7","key":"10.1111\/j.1529-8019.2009.01224.x-BIB65","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"19","key":"10.1111\/j.1529-8019.2009.01224.x-BIB66","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/S0264-410X(99)00524-1","article-title":"Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults","volume":"18","author":"Knoll","year":"2000","journal-title":"Vaccine"},{"issue":"11","key":"10.1111\/j.1529-8019.2009.01224.x-BIB67","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0264-410X(99)00354-0","article-title":"Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines","volume":"18","author":"Czeschinski","year":"2000","journal-title":"Vaccine"},{"issue":"32","key":"10.1111\/j.1529-8019.2009.01224.x-BIB68","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1016\/S0264-410X(01)00240-7","article-title":"A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults","volume":"19","author":"Joines","year":"2001","journal-title":"Vaccine"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB69","unstructured":"69.\u2002Inactivated influenza vaccine. Available at: http:\/\/www.cdc.gov\/flu\/keyfacts.htm. Accessed October 30, 2008."},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB70","unstructured":"70.\u2002Vaccine information statement. Live, attenuated influenza vaccine. Avaialble at: http:\/\/www.cdc.gov\/flu\/keyfacts.htm. Accessed October 30, 2008."},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01224.x-BIB71","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3201\/eid0905.020562","article-title":"Global illness and deaths caused by rotavirus disease in children","volume":"9","author":"Parashar","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"14","key":"10.1111\/j.1529-8019.2009.01224.x-BIB72","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1995.03530140055032","article-title":"Trends of diarrheal disease - associated mortality in US children, 1968 through 1991","volume":"274","author":"Kilgore","year":"1995","journal-title":"JAMA"},{"issue":"17","key":"10.1111\/j.1529-8019.2009.01224.x-BIB73","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jama.279.17.1371","article-title":"Cost-effectiveness analysis of a rotavirus immunization program for the United States","volume":"279","author":"Tucker","year":"1998","journal-title":"JAMA"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01224.x-BIB74","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01.inf.0000215234.91997.21","article-title":"Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002","volume":"25","author":"Charles","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-12","key":"10.1111\/j.1529-8019.2009.01224.x-BIB75","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Parashar","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.103.1.e3","article-title":"Perinatal risk factors for infant hospitalization with viral gastroenteritis","volume":"103","author":"Newman","year":"1999","journal-title":"Pediatrics"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01224.x-BIB77","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3201\/eid0912.030374","article-title":"Novel lyssaviruses isolated from bats in","volume":"9","author":"Botvinkin","year":"2003","journal-title":"Russia. Emerg Infect Dis"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01224.x-BIB78","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1017\/S0950268803001481","article-title":"European bat lyssaviruses: an emerging zoonosis","volume":"131","author":"Fooks","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB79","unstructured":"79.\u2002Centers for Disease Control and Prevention. Rabies vaccine. Available at: http:\/\/www.cdc.gov\/vaccines\/pubs\/vis\/downloads\/vis-rabies.pdf. Accessed October 30, 2008."},{"issue":"11","key":"10.1111\/j.1529-8019.2009.01224.x-BIB80","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa043018","article-title":"Transmission of rabies virus from an organ donor to four transplant recipients","volume":"352","author":"Srinivasan","year":"2005","journal-title":"N Engl J Med"},{"issue":"RR-3","key":"10.1111\/j.1529-8019.2009.01224.x-BIB81","first-page":"1","article-title":"Human rabies prevention - United States, 2008: recommendations of the Advisory Committee on Immunization Practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm Rep"},{"issue":"17","key":"10.1111\/j.1529-8019.2009.01224.x-BIB82","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1056\/NEJMra020025","article-title":"Diagnosis and management of smallpox","volume":"346","author":"Breman","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB83","unstructured":"83.\u2002Centers for Disease Control and Prevention. Smallpox fact sheet. Available at: http:\/\/www.bt.cdc.gov\/agent\/smallpox\/overview\/disease-facts.asp. Accessed October 30, 2008."},{"issue":"RR-10","key":"10.1111\/j.1529-8019.2009.01224.x-BIB84","first-page":"1","article-title":"Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001","volume":"50","author":"Rotz","year":"2001","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01224.x-BIB85","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB86","unstructured":"86.\u2002Centers for Disease Control and Prevention. Smallpox vaccine and monkeypox. Available at: http:\/\/www.cdc.gov\/ncidod\/monkeypox\/pdf\/smpoxvaccmpox.pdf. Accessed October 30, 2008."},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB87","unstructured":"87.\u2002Centers for Disease Control and Prevention. Japanese encephalitis fact sheet. Available at: http:\/\/www.cdc.gov\/ncidod\/dvbid\/jencephalitis\/facts.htm. Accessed October 30, 2008."},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB88","unstructured":"88.\u2002Centers for Disease Control and Prevention. Japanese encephalitis vaccine, 5\/11\/05. Available at: http:\/\/www.cdc.gov\/vaccines\/pubs\/vis\/downloads\/vis-je.pdf. Accessed October 30, 2008."},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB89","unstructured":"89.\u2002World Health Organization. District guidelines for yellow fever surveillance. World Health Organization, 1998. Available at: http:\/\/www.who.int\/vaccines-documents\/DocsPDF\/www9834.pdf. Accessed October 30, 2008"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB90","doi-asserted-by":"crossref","DOI":"10.1097\/00000441-195610000-00061","volume-title":"Yellow fever vaccination","author":"Smithburn","year":"1956"},{"issue":"RR-17","key":"10.1111\/j.1529-8019.2009.01224.x-BIB91","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB92","unstructured":"92.\u2002Centers for Disease Control and Prevention. US Department of Health and Human Services, Centers for Disease Control and Prevention. Yellow fever, 11\/9\/2004. Available at: http:\/\/www.cdc.gov\/ncidod\/dvbid\/YellowFever\/vaccine\/index.html. Accessed October 30, 2008."},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB93","volume-title":"Yellow fever (Chapter 34)","author":"Monath","year":"1999"},{"issue":"9276","key":"10.1111\/j.1529-8019.2009.01224.x-BIB94","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01224.x-BIB95","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thai"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01224.x-BIB96","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.1966.03110190153047","article-title":"Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child","volume":"198","year":"1966","unstructured":"96.\u2002Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child. JAMA 1966: 198 (6): 671-672.","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2009.01224.x-BIB97","volume-title":"Health information for international travel 2008","author":"Centers for Disease Control and Prevention","year":"2007"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01224.x-BIB98","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01224.x-BIB99","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMicm050576","article-title":"Images in clinical medicine. Koplik's spots","volume":"354","author":"Tierney","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01224.x-BIB100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMp068149","article-title":"Measles in the United States, 2006","volume":"355","author":"Mulholland","year":"2006","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1111\/j.1529-8019.2009.01224.x-BIB101","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01224.x-BIB102","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMcp031540","article-title":"Prevention of hepatitis A with the hepatitis A vaccine","volume":"350","author":"Craig","year":"2004","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1111\/j.1529-8019.2009.01224.x-BIB103","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMicm010892","article-title":"Images in clinical medicine. Eczema vaccinatum - a timely reminder","volume":"346","author":"Moses","year":"2002","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1111\/j.1529-8019.2009.01224.x-BIB104","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMp0707161","article-title":"Dengue and yellow fever - challenges for the development and use of vaccines","volume":"357","author":"Monath","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2009.01224.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2009.01224.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T16:09:22Z","timestamp":1684944562000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2009.01224.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2009.01224.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}